Abstract: Calpain (calcium-activated neutral protease) has been implicated as playing a role of neuronal injury in cerebral ischemia and excitotoxicity. Here we report that, in addition to extreme excitotoxic conditions [N-methyl-D-aspartate (N MDA), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kainate challenges], other neurotoxins such as maitotoxin, A231 87, and okadaic acid also induce calpain activation, as detected by m-calpain autolytic fragmentation and nonerythroid a-spectrin breakdown. Under the same conditions, calmodulin-dependent protein kinase Il-a (CaMPK-lla) and neuronal nitric oxide synthase (nNOS) are both proteolytically cleaved by calpain. Such fragmentation can be reduced by calpain inhibitors (acetylLeu-Leu-Nle-CHO and PD151746). In vitro digestion of protein extract from cortical cultures with purified~.t-and m-calpain produced fragmentation patterns for CaMPKIke and nNOS similar to those produced in situ. Also, several other calpain-sensitive calmodulin-binding proteins (plasma membrane calcium pump, microtubule-associated protein 2, and calcineurin A) and protein kinase C-a are also degraded in neurotoxin-treated cultures. Lastly, in a rat pup model of acute excitotoxicity, intrastriatal injection of NMDA resulted in breakdown of CaMPKla and nNOS. The degradation of CaMPK-lla, nNOS, and other endogenous calpain substrates may contribute to the neuronal injury associated with various neurotoxins.
. Direct challenges of neuronal cultures with hypoxia or extreme excitotoxic conditions high concentrations of N-methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kainate] can lead to calpain activation and neuronal death (Siman and Noszek, 1988; Lee et al., 1991) . It has been suggested that the breakdown of spectrin results in a disruption of the cytoskeleton network. The formation of a-spectrin breakdown products (SBDPs) of 150 and 145 kDa is perhaps the best-characterized marker for calpain overactivation (Saido et al., 1993; Wang et al., 1996b) .
In the present study, we extend these observations by showing that calpain is activated when cerebrocortical neurons are challenged with various neurotoxins, including calcium ionophore, maitotoxin (MTX), okadaic acid (OK), and kainate. Furthermore, besides aspectrin, the study of target proteins for calpain in neurotoxic conditions is rather limited; neurofilaments and microtubule-associated protein 2 (MAP2) appear to be the only other ones reported (Fischer et al., 1991) . We previously described that purified calmodu-lin-binding proteins (CaMBPs), as a group, are selectively vulnerable to calpain in vitro (Wang et a!., 1989a,b) . In this study, we examine the integrity of various CaMBPs in cells challenged with various neurotoxins. We report that two important neuronal calmodulin-dependent enzymes, calmodulin-dependent protein kinase Ila (CaMPK-IIa) and neuronal nitric oxide synthase (nNOS) (Nairn et al., 1985; Nathan and Xie, 1994) are among those CaMBPs that are proteolyzed by calpain in neurotoxin-injured cells.
MATERIALS AND METHODS

Fetal rat cerebrocortical cultures and neurotoxin challenges
All procedures described in this study were carried out in compliance with the NIH Guide for Care and Use of Laboratory Animals, guidelines from the Society for Neuroscience, and the Parke-Davis animal use committee. Cerebrocortical cells were harvested from fetal rats (Sprague -Dawley) on their 18th day of gestation and cultured with Dulbecco's modified Eagle's medium (DMEM)/F12 medium containing 10% horse and 6% fetal bovine serum (heat-inactivated) in 96-well poly-L-lysine-coated plates as described previously (Hajimohammadreza et al., 1995) . Nonneuronal cell division was halted 3 days into culture by adding 25
.tg/mluridine and 10 ,ug/ml 5-fiuoro-2'-deoxyuridine. On the 17th day postplating, the cultures were washed three times with serum-free medium, and calpain inhibitor was added at this point for a 1-h preincubation, if desired. The cultures were then challenged with various neurotoxins as follows: 250 1.tM NMDA for 30 mm (unless stated otherwise) before replacing with normal serum-free medium for 24 h; 200 1iM AMPA (with 30 j.tM cyclothiazide) or 100 iMkainate in serum-free medium for 24 h; or 1 nM MTX for 1 h, 100 nM OK for 1 h, or 10~M A23187 for 1 h before replacing with normal serum-free medium for 24 h. All cultures are maintained in a 37°C oxygenated incubator (21% 02, 8% CU2, and 71% N2) except during medium changes. Various concentrations of NMDA have also been included. Under one condition, calcium-free DMEM was used instead of the normal DMEM to examine the effect of extracellular calcium. Neuronal death was assessed by measuring the amount of the cytosolic enzyme lactate dehydrogenase (LDH) released into the medium as described previously (Koh and Choi, 1987) . At 24 h after neurotoxin challenges, the cerebrocortical neurons were significantly swollen but generally stayed attached, with only 20-30% neurons disintegrated. We chose this time point for protein extraction to standardize better our comparison of proteolysis patterns with different neurotoxic challenges. Cellular proteins were extracted as described previously (Wang et al., 1996a) .
In vitro nNOS and CaMPK-IIa proteolysis with calpains
Total protein was extracted from control cultures using the Triton X-100 method and used as a source of a-spectrin. Cortical neuronal cell protein extract (20~of protein) was treated with 1.5 j.tg of purified ,v-calpain or m-calpain (Wang et al., l988a) in 100mM HEPES (pH 7.2 at 25°C),10mM dithiothreitol, 10% (vol/vol) glycerol, and 1 mM CaC12 for 90 mm. The digestion was terminated by addition of an equal volume of sodium dodecyl sulfate-containing sample buffer for polyacrylamide gel electrophoresis. Samples were split into four sets. Both sets were subjected to electrophoresis and western blotting.
NMDA-induced injury in rat pups
Sprague-Dawley rat pups (Charles River Laboratories, Portage, MI, U.S.A.) were used on postnatal day 6-7 (average weight, 14 g). Animals were anesthetized by ethyl ether before 25 nmol of NMDA in the form of a saline solution (0.5~zlof 7.35 mg/ml) was stereotaxically injected into the right posterior striatum with the aid of a stereotaxic platform. Rat pups were allowed to recover for 2 h in an incubator kept at 36°Cwith a thermostat-controlled heating coil and thenreturned to their cages. After 24 h, the pups were decapitated, and their cortical hemispheres were removed. The hemispheres were individually submerged in -70°Ccooled isopentane. Frozen brains were powdered with a precooled mortar and pestle over dry ice. About 50 mg of the samples was added to 0.5 ml of a homogenization buffer containing 2% (wt/vol) sodium dodecyl sulfate, 20 mM Tris-HC1 (pH 7.4), 5 mM EDTA, 5 mM EGTA, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 10 jig/ml 4-(2-aminoethyl)benzenesulfonylfluonde, 5~ig/ml leupeptin, 10 jsg/ml pepstatin, 10~sg/ml N-a-p-tosyl-L-lysine chloromethyl ketone, and 10~ig/ml N-a-p-tosyl-L-phenylalanine chloromethyl ketone for 15-20 mm to produce a clear lysate. One hundred microliters of trichloroacetic acid [100% (wt/ vol) I was then added. The precipitated proteins were collected by centrifugation and washed with 1 ml of 2.5% tnchloroacetic acid. The protein pellets were resolubilized with 50 p1 of 3 M Tris base and stored at -20°Cuntil use (Wang etal., 1996a,b) .
Protein sample analysis
Protein concentration in tissue extract was estimated with a modified Lowry assay (Bio-Rad). Samples (15 pg of protein) were electrophoresed on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (4-20% acrylamide) with a Tris-glycine running buffer system and then transferred onto a PVDF membrane (pore size, 0.2 pm) with a Tris-glycine buffer system using a semidry electrotransferring unit (BioRad) at 20 mA for 1.5-2 h. The blots were probed with anti-a-spectrin (monoclonal; Chemicon), anti-CaMPK-IIa 
RESULTS
Cerebrocortical cultures challenged with extreme excitotoxic conditions [250 pM NMDA, 200 ,uM AMPA (with 30 1aM cyclothiazide), and 100 jiM kainate 1 suffer a massive neuronal death 24 h after the initiation of insults (Fig. 1) . Similarly, the calcium channel opener MTX (0.1 nM), the calcium ionophore A23187, and the protein phosphatase 1A and 2A inhibitor OK (100 nM) all induced comparable levels of neurotoxicity at 24 h ( Fig. 1) , with the exception of A23 187, which seems to produce a higher LDH release.
To assess calpain activation, we relied on two established methods: the presence of calpain autolysis and evidence of SBDPs. Using protein extracts from control and neurotoxin-treated cells (at 24 h), we performed western blots to examine the proteolytic phenomenon. At 24 h after neurotoxin challenges (high concentrations), the cerebrocortical neurons were significantly swollen but stayed attached;~20-30% of the neurons had disintegrated. We chose this time point to standardize the comparison of proteolysis levels due to different neurotoxin treatment. On the other hand, we found that with milder challenges (lower NMDA concentrations) or at earlier time points after 250 pM NMDA challenge, e.g., 1 h, the neurons did not show significant morphological changes (see below and Fig.   4 ). An antibody that reacts preferentially with rn-calpain detected the intact 80-kDa subunit of m-calpain in control cultures ( Fig. 2A) . In NMDA-, kainate-, AMPA-, and OK-treated cells, a major fragment of 32 kDa and several minor fragments of 55, 40, and 26 kDa were observed ( Fig. 2A) . MTX-and A23 187-treated cells had the most extensive proteolysis of mcalpain, to a 26-kDa fragment instead of the 32-kDa fragment ( Fig. 2A) . The 55-, 40-, and 26-kDa fragments are also produced when purified porcine rn-calpain is subjected to prolonged autolysis (on western blots probed with the same antibody) (see Fig. 2A , right inset), consistent with a previous report (Nishimura and Goll, 1991) . The 32-kDa m-calpain fragment was not observed with purified m-calpain (Fig. 2 , inset); thus, it appears that the 32-kDa fragment observed in certain neurotoxin treatments can be further fragmented to 26 kDa in the case of extreme calpain activation as with MTX or A23 187 treatment. In parallel, a-spectrin (280 kDa) was also fragmented to 150-and 145-kDa species in cells treated with neurotoxins (Fig. 2B) . After neurotoxin challenges, the 54-kDa CaMPK-IIa degraded to a 35-kDa fragment, concurrent with the loss of the intact protein mass (Fig. 3A) . Again, MTXand A23 187-treated cells had the most significant loss of intact CaMPK-IIa, whereas OK-treated cells had the least loss. We also observed that the homologous CaMPK-II (/3 isoform) was also fragmented in a similar manner (data not shown). In parallel, neurotoxins also induced the breakdown of nNOS (161 kDa) to 130-and 65-kDa fragments (Fig. 3B) .
Using 250 pM NMDA as the challenge, we found that the proteolysis of CaMPK-IIa and nNOS was rapid, with significant fragment levels detected as early as 1 h (Fig. 4A and C) . We also observed that the proteolysis patterns were extracellular calcium-dependent, as omission of extracellular Ca 2~completely inhibited fragmentation of all three proteins (Fig. 4A) . As 250 pM NMDA represents extreme excitotoxic challenge, we examined the fragmentation of a-spectrin, CAMPK-IIa, and nNOS over a range of NMDA concentrations (10, 25, 50, 100, and 250 pM) . We observed that with as little as 10-25 pM NMDA, fragmentation of these proteins was also induced at a lower level, which provided a good correlation with LDH release (Fig. 4B) . To confirm that the CaMPK-IIa and nNOS breakdown is mediated by calpain, we used the active site-acting calpain inhibitor I (Calplnh-I; acetylLeu-Leu-Nle-CHO) as well as the novel calcium-binding domain-targeting PD 151746 [3-(5-fiuoro-3-in- dolyl ) -2-mercapto-(Z )-2-propenoic acid I (Wang et al., 1996b) . We observed that the NMDA-induced SBDP of 145 kDa was significantly and strongly inhibited by Calplnh-I and PD151746 (Fig. 4A and Table  1 ). The larger SBDP (150 kDa) is apparently much more difficult to inhibit. The accumulation of the 150-kDa SBDP actually increased in calpain inhibitortreated cells ( Fig. 4A ; data not shown for PD151746), probably owing to the fact that further breakdown to the 145-kDa fragment was inhibited, as reported previously (Harris et al., 1988; Wang et al., 1996b) . Under these conditions, the fragmentation of CaMPKha and nNOS was almost completely abolished by Calplnh-I and PD151746 (Fig. 4A and Table 1 ). Because Calplnh-I is known to inhibit cathepsin B and possibly other cysteine proteases (Wang et al., 1996b) , we also used the ICE/caspase inhibitor carbobenzoxy- (Dolle et al., 1994) as well as the cathep- Towatari et al., 1991) : They inhibited the formation of the above-mentioned breakdown products by <30% (Table 1) .
Using a range of [NMDA], we also found that the breakdown of a-spectrin, CaMPK-IIa, and nNOS increases in an NMDA dose-dependent manner (Fig.  4B ). Even as little as 10-25 pM NMDA evoked a small level of proteolysis. Similarly, using 250 pM NMDA, we found that the proteolysis response was very rapid, correlated closely to the LDH release (Fig. 4C) .
In another approach, total protein extracts from control cerebrocortical cultures were subjected to in vitro digestion with purified calpains. The breakdown of intact a-spectrin by both p-and m-calpain to the SBDP doublet was as expected (Fig. 5A) . The formation of the 145-kDa species was blocked by Calplnh-I as well as the calcium-binding site-acting calpain inhibitor PD151746. Again, the 150-kDa SBDP was not significantly blocked by PD 150606 [3-(4-iodophenyl) -2-mercapto-(Z ) -2-propenoic acid]. In parallel, CaMPKha in the extracts was also partially degraded to the 35-kDa fragment (Fig. SB) . Calplnh-I and, to a lesser extent, PD 150606 attenuated this effect. nNOS was also degraded to 140-, 130-, and 65-kDa fragments, and Calplnh-I again effectively inhibited this fragmentation, whereas PD 150606 was only partially effective (Fig. 5C ). Overall, PD150606 was less effective in blocking calpain substrate fragmentation, probably because of its uncompetitive, non-active site-binding properties (Wang et a!., l996b). As a control, actin was not degraded at all by calpain (Fig. SD) . In general, the fragmentation patterns of a-spectrin, CaMPKIla, and nNOS generated by calpain in vitro match closely with those produced in cell culture.
We also investigated the vulnerability of other calpain substrates to proteolysis in our neurotoxicity para- digm using a panel of antibodies against several CaMBPs and PKC (a isoform) (Fig. 6) . We observed that the plasma membrane calcium pump (136 kDa) was indeed fragmented to 127-and 85-kDa fragments. MAP2 (200 kDa) was almost completely degraded under these conditions. Calcineurin A (60 kDa) was fragmented to 55 kDa (Fig. 6) . Similarly, PKC-a broke down to a major 43-kDa fragment-the socalled M-form of the kinase (Kishimoto et al., 1989) . As a control, actin (43 kDa) was not degraded under the same conditions. To extend our investigation to an in vivo model, we used the NMDA neurotoxicity paradigm in rat pups (McDonald et al., 1989) . At 24 h after the NMDA injection, the cerebral hemispheres were separately analyzed for calpain-mediated substrate breakdown. As reported previously by us using a hypoxic-ischemic challenge (Vartanian et al., 1996) , SBDPs of 150 and 145 kDa were identified prominently on the ipsilateral side and only weakly on the contralateral side of NMDA-treated pups. No SBDPs were found in the sham-treated pups (Fig. 7) , suggesting that our method of protein extraction did not generate postmortem artifacts, e.g., nonspecific protein breakdown. Under the breakdown was also observed on the ipsilateral side of NMDA-treated pups. It is interesting that significant levels of nNOS fragments also accumulated on the contralateral side in injured animals (Fig. 7B) . The fragmentation patterns ofboth proteins were very similar to those observed in vitro (Fig. 2) . Again, little breakdown of both proteins was observed in the shams (Fig. 7) .
DISCUSSION
In this study, we have demonstrated that calpain is activated when cerebrocortical neurons are challenged with various neurotoxins, as evidenced by the distinct SBDP doublet and m-calpain autolysis (Fig. 2) . The autolysis of m-calpain appeared most extensive when cells were treated with agents that evoked direct calcium influx (A23 187 and MTX). One would assume that the lower-calcium-requiring p-calpain would also undergo similar autolytic changes; unfortunately, our antibody that was raised against the human enzyme did not cross-react significantly with the rat p-calpain in these cell cultures. Further studies are needed to evaluate the relative contribution of the calpain isoforms in neurotoxicity. We have also reported for the first time that CaMPK-IIa is fragmented by calpain in cultured neurons under neurotoxic conditions (Figs. 3  and 4) . In vitro digestion of neuronal extracts with purified calpains produced essentially the same pattern of CaMPK-IIa fragmentation (Fig. 5) . Furthermore, CaMPK-IIa breakdown was also evident in an in vivo model of NMDA toxicity (Fig. 7) . CaMPK-IIa, particularly the a isoform, is highly enriched in neuronal postsynaptic membranes and can phosphorylate various substrate proteins (such as the AMPA receptor and calcium channels) Hell et al., 1993a,b; Tan et al., 1994) . CaMPK-II has also been implicated in the induction of long-term potentiation in the hippocampus (Malenka et al., 1989; Malinow et a!., 1989) . Several research groups have reported that during ischemia and excitotoxicity, CaMPK-II activity was altered (Kochhar et al., 1991; Morioka et al., 1992; Yamamoto et al., 1992; Churn et al., 1993) . Alteration of its activity could significantly compromise synaptic functions. Hajimohammadreza et al. (1995) reported that a CaMPK-II-specific inhibitor, KN62, can partially attenuate excitotoxicity and hypoxic damage. It has been suggested that NMDA-induced CaMPK-II activation may be intimately involved in a positive feedback mechanism through phosphorylation-mediated activation of various ion channel proteins Hell et al., 1993a,b; Tan et al., 1994) . The findings here further extend this concept. The major fragment of CaMPKlIa in these studies is~=35 kDa. Kwiatkowski and King (1989) previously reported that a CaMPK-II fragment of '-35 kDa, which possessed the whole catalytic domain but had lost the calmodulin-binding domain, was constitutively active and independent of calmodulin control. Furthermore, we found that the homologous~3isoform of CaMPK-II was also proteolyzed by calpain in a similar manner (data not shown). Work is now in progress to identify the exact cleavage sites in CaMPK-II isoforms.
The neurotoxin-induced fragmentation of nNOS is equally intriguing and novel. Because this enzyme is a CaMBP, its susceptibility to calpain is expected to some extent (Wang et al., 1989b ). Yet, this is the first report of such an observation. We have demonstrated nNOS proteolysis both in situ (Figs. 3 and 4 ) and in vivo (Fig. 7) . nNOS is an important neuronal enzyme that produces nitric oxide, which can serve as a retrograde second messenger for neuron-to-neuron communications (Collier and Vallance, 1989; Ross et al., 1990) . On the other hand, neuroprotective effects of nitric oxide synthase inhibitors have also been documented (Buisson et al., 1992; Hamada et al., 1993) . We reported here the presence of two major fragments (130 and 65 kDa) of nNOS on western blots (Figs. 3 and 4). We propose that they are derived from sequential cleavages. At present, we do not know the sites of the cleavage and whether either fragment possesses enhanced or reduced nitric oxide synthase activity. Further studies are planned to examine these issues.
In this study, we propose that calpain is the protease involved in the proteolysis of CaMPK-IIa and nNOS, because (a) their breakdown in situ was prevented by two classes of calpain inhibitors as well as by calcium chelation, but not by other cysteine protease inhibitors (Fig. 4 and Table 1), (b) the in situ fragmentation patterns were identical to those produced in vitro using purified calpains (compare Fig. 3 to Fig. 5) , and (c) the NMDA dose-response and time course studies illustrated that the breakdown of CaMPK-IIa and nNOS matched closely with that of a-spectrin, a well-established calpain substrate (Siman and Noszek, 1988; Lee et al., 1991; Hajimohammadreza et al., 1994) . As CaMBPs are a group of vulnerable calpain substrates (Wang et al., 1989b) , we further investigated the sensitivity of several of them to proteolysis in neurotoxintreated cells (Fig. 6) . Besides a-spectrin, MAP2 is perhaps the most vulnerable calpain substrate and is almost completely degraded under all neurotoxic conditions (Fischer et al., 1991) . MAP2 degradation has been documented in hypoxia and in NMDA-induced toxicity (Siman and Noszek, 1988; Taft et al., 1992) . PKC-a, a well-documented calpain substrate (in vitro and in vivo), is found to be partially cleaved to the so-called M-form (43 kDa), which is constitutively active and is phospholipid-independent (Kishimoto et al., 1989) . The plasma membrane Ca 2~-ATPase (PMCA) is degraded to two proteolytically activated fragments (127 and 85 kDa), as has been previously reported under in vitro conditions (Wang et a!., 1988a,b) . The large subunit of calmodulin-activated protein phosphatase, calcineurin-A (60 kDa), is also degraded to a 55-kDa fragment (Fig. 6) . A 55-kDa fragment of calcineurin-A generated by in vitro calpain digestion was previously reported to have higher activity compared with the intact protein (Tallant et al., 1988; Wang et al., 1989a) . Thus, it is likely that the 55-kDa fragment we observed in situ represents a proteolytically activated form of the enzyme. This is the first report that documents the fragmentation of PMCA and calcineurin-A in degenerative neurons in culture. To illustrate that the breakdown of these calpain substrates is unique rather than part of a general protein breakdown phenomenon, we noted that actin in neuronal cells was practically unaffected under identical conditions. Thus, in neurons challenged with a neurotoxin, there is a concerted attack on various CaMBPs, including
CaMPK-IIa and nNOS. It is interesting that the breakdown of these proteins directly correlated with LDH release as we varied the level of NMDA challenge (Fig. 4B) . It would thus suggest that the breakdown of these proteins only occurs in pathophysiological conditions. It is not hard to imagine the profound alterations in cell functions that arise. Previous studies have illustrated that calpain inhibitors can protect against excitotoxic and hypoxic injury both in vitro and in vivo (Lee et a!., 1991; Wang et al., 1996b) . It seems likely that the protective effects of calpain inhibition are derived from limiting the fragmentation of various endogenous calpain substrates. Therefore, the present study extends our understanding of the detrimental effects of calpain overactivation under neurotoxic conditions.
